The acquisition combines BPTC’s broad chemistry, manufacturing and controls consulting services with BDO’s existing capabilities in the life sciences and biopharmaceutical industries.
Founded in 1994, BPTC was a biologics CMC consulting firm, providing a full range of technical, regulatory, and strategic assistance related to the development and commercialization of biopharmaceutical products. BPTC assisted clients in developing manufacturing processes and strategies that enhanced the overall value of their products, while de-risking product development.
Howard L. Levine, Ph.D., BPTC founder, president and CEO will become managing director and national leader of the Bioprocess Technology Group (BPTG) within BDO’s Life Sciences practice and the majority of BPTC’s consultants will join the new BPTG. “Since our inception, we’ve worked with companies to advance and de-risk the biotherapeutic development process, address unmet medical needs and increase patient access to novel medicines,” said Levine. “We’re excited to join BDO’s Life Sciences practice to support clients across the entire product development and company lifecycles.”
“We are pleased to welcome BPTC’s knowledge and resources to enhance our focus in the life sciences industry and deepen our biopharmaceutical product development offerings,” said Eric Jia-Sobota, national leader of BDO’s Industry Specialty Services and Life Sciences practices. “Joining forces with BPTC strengthens our ability to assist life sciences companies in managing risk, maximizing profitability and fostering continued innovation to unlock new value and deliver improved outcomes.”
About BioProcess Technology Consultants
BPTC is the recognized worldwide leader in biologics CMC consulting, providing a full range of technical, regulatory, and strategic assistance to pharmaceutical and biotechnology companies in the development and commercialization of biopharmaceutical products. The company works with clients globally to find and apply solutions to the challenges of biopharmaceutical product development from clone to commercial®. BPTC helps develop manufacturing processes and strategies that enhance the overall value of client companies, de-risk biopharmaceutical development, and accelerate the advancement of new products from clone to clinic®. BPTC also helps investors, service providers, and companies make informed decisions by providing technical due diligence services and business evaluations of new products as well as technologies for product discovery, development, or commercialization. For more information about BPTC, visit http://www.bptc.com. Follow us on Twitter at @bptcglobal or LinkedIn at http://www.linkedin.com/company/bioprocess-technology-consultants-inc.
About BDO USA
BDO USA, LLP is a U.S. professional services firm providing assurance, tax, and advisory services to a wide range of publicly traded and privately held companies. For more than 100 years, BDO has provided quality service through the active involvement of experienced and committed professionals. The firm serves clients through more than 60 offices and over 650 independent alliance firm locations nationwide. As an independent Member Firm of BDO International Limited, BDO serves multi-national clients through a global network of more than 80,000 people working out of 1,591 offices across 162 countries. BDO USA, LLP is the U.S. member of BDO International Limited, a UK company limited by guarantee, and forms part of the international BDO network of independent member firms. BDO is the brand name for the BDO network and for each of the BDO Member Firms. For more information please visit: www.bdo.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190401005081/en/
Source: BioProcess Technology Consultants Inc.
View this news release online at:
http://www.businesswire.com/news/home/20190401005081/en
